Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels | Zendy

Juan Jesús Carrero | Zendy; Anna Witasp | Zendy; Peter Stenvinkel | Zendy; Abdul Rashid Qureshi | Zendy; Olof Heimbürger | Zendy; Peter Bárány | Zendy; Mohamed E. Suliman | Zendy; Björn Anderstam | Zendy; Bengt Lindholm | Zendy; Louise Nordfors | Zendy; M. Schalling | Zendy; John Axelsson | Zendy

Open Access

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels

Author(s) -

Juan Jesús Carrero,

Anna Witasp,

Peter Stenvinkel,

Abdul Rashid Qureshi,

Olof Heimbürger,

Peter Bárány,

Mohamed E. Suliman,

Björn Anderstam,

Bengt Lindholm,

Louise Nordfors,

M. Schalling,

John Axelsson

Publication year - 2009

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfp587

Subject(s) - medicine , endocrinology , appetite , ghrelin , kidney disease , anorexia , leptin , obesity , hormone

Anorexia is a common complication of chronic kidney disease (CKD), while novel animal and human data suggest a role for visfatin in regulating feeding behavior. We hypothesized that increased visfatin levels in CKD patients may be involved in the regulation of appetite and nutrient homeostasis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research